Sage Therapeutics Inc SAGE

NAS: SAGE | ISIN: US78667J1088 12/12/2024

5,670 USD (-3,74%)

(-3,74%) 12/12/2024

Grafiek Sage Therapeutics Inc

Grafiek Sage Therapeutics Inc

1 dag1d -3,74%
1 week1w 1,07%
1 maand1m -1,05%
3 maanden3m -27,59%
6 maanden6m -50,70%
1 jaar1j -73,44%
5 jaar5j -92,22%

Sage Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

10 september 2024 · Sage Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAGE · Persbericht

19 augustus 2023 · SAGE INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Sage Therapeutics, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm · Persbericht

Profiel Sage Therapeutics Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.sagerx.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

CEO: Jeffrey Jonas

Werknemers: 780

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe